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Abstract
Background: Neovascularization (angiogenesis) is a multistep process, controlled by opposing regulatory factors,
which plays a crucial role in several ocular diseases. It often results in vitreous hemorrhage, retinal detachment,
neovascularization glaucoma and subsequent vision loss. Hypoxia is considered to be one of the key factors to
trigger angiogenesis by inducing angiogenic factors (like VEGF) and their receptors mediated by hypoxia inducible
factor-1 (HIF-1a) a critical transcriptional factor. Another factor, nuclear factor kappa B (NFB) also regulates many
of the genes required for neovascularization, and can also be activated by hypoxia. The aim of this study was to
elucidate the mechanism of interaction between HRPC and HUVEC that modulates a neovascularization response.
Methods: Human retinal progenitor cells (HRPC) and human umbilical vein endothelial cells (HUVEC) were
cultured/co-cultured under normoxia (control) (20% O2) or hypoxia (1% O2) condition for 24 hr. Controls were
monolayer cultures of each cell type maintained alone. We examined the secretion of VEGF by ELISA and influence
of conditioned media on blood vessel growth (capillary-like structures) via an angiogenesis assay. Total RNA and
protein were extracted from the HRPC and HUVEC (cultured and co-cultured) and analyzed for the expression of
VEGF, VEGFR-2, NFB and HIF-1a by RT-PCR and Western blotting. The cellular localization of NFB and HIF-1a
were studied by immunofluorescence and Western blotting.
Results: We found that hypoxia increased exogenous VEGF expression 4-fold in HRPC with a further 2-fold increase
when cultured with HUVEC. Additionally, we found that hypoxia induced the expression of the VEGF receptor
(VEGFR-2) for HRPC co-cultured with HUVEC. Hypoxia treatment significantly enhanced (8- to 10-fold higher than
normoxia controls) VEGF secretion into media whether cells were cultured alone or in a co-culture. Also, hypoxia
was found to result in a 3- and 2-fold increase in NFB and HIF-1a mRNA expression by HRPC and a 4- and 6-fold
increase in NFB and HIF-1a protein by co-cultures, whether non-contacting or contacting.
Treatment of HRPC cells with hypoxic HUVEC-CM activated and promoted the translocation of NFB and HIF-1a to
the nuclear compartment. This finding was subsequently confirmed by finding that hypoxic HUVEC-CM resulted in
higher expression of NFB and HIF-1a in the nuclear fraction of HRPC and corresponding decrease in cytoplasmic
NFB and HIF-1a. Lastly, hypoxic conditioned media induced a greater formation of capillary-like structures
(angiogenic response) compared to control conditioned media. This effect was attenuated by exogenous anti-
human VEGF antibody, suggesting that VEGF was the primary factor in the hypoxic conditioned media responsible
for the angiogenic response.
Conclusions: These findings suggest that intercellular communications between HRPC and HUVEC lead to the
modulation of expression of transcription factors associated with the production of pro-angiogenic factors under
hypoxic conditions, which are necessary for an enhanced neovascular response. Our data suggest that the hypoxia
treatment results in the up-regulation of both mRNA and protein expression for VEGF and VEGFR-2 through the
* Correspondence: rkumar@msm.edu
1Department of Microbiology, Biochemistry and Immunology, Morehouse
School of Medicine, 720 Westview Drive, S.W., Atlanta, Georgia, United States
30310
Full list of author information is available at the end of the article
Kumar et al. Vascular Cell 2011, 3:27
http://www.vascularcell.com/content/3/1/27 VASCULAR CELL
© 2011 Kumar et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
translocation of NFB and HIF-1a into the nucleus, and results in enhanced HRPC-induced neovascularization.
Hence, a better understanding of the underlying mechanism for these interactions might open perspectives for
future retinal neovascularization therapy.
Keywords: Neovascularization, Human retinal progenitor cells (HRPC), Human umbilical vein endothelial cells
(HUVEC), Hypoxia, Vascular endothelial growth factor, Conditioned medium, Co-culture
Background
Neovascularization (angiogenesis) is defined as the for-
mation of new blood vessels by sprouting of endothelial
cells from pre-existing vessels. This is a multistep pro-
cess, which is controlled by opposing regulatory factors
and involves endothelial cells migration, proliferation,
degradation of the underlying basement membrane, and
assembly into tubes [1,2]. Neovascularization plays a
crucial role in several ocular diseases, including age-
related macular degeneration, retinopathy of prematurity
and proliferative diabetic retinopathy, which are major
causes of blindness [3-6]. It often results in vitreous
hemorrhage, retinal detachment, neovascularization
glaucoma and subsequent vision loss. It is believed that
tissue damage can stimulate release of angiogenic factors
resulting in capillary proliferation [7-9]. Neovasculariza-
tion is also essential for tissue repair, fetal development,
and the female reproductive cycle. Changes in the regu-
latory factors, e.g., VEGF, may be directly related to
pathological retinal diseases. These mediators can stimu-
late neovascularization directly by interacting with
receptors on the endothelial cell surface, or indirectly by
attracting and activating accessory cells.
Hypoxia is considered to be one of the key factors
triggering angiogenesis by inducing angiogenic factors
(like VEGF) and their receptors [10-12]. A number of
studies [13-15] have shown that hypoxia plays a major
role in triggering ocular neovascularization by inducing
several angiogenic factors (e.g., vascular endothelia
growth factors (VEGF) fibroblast growth factor (FGF),
platelet-derived growth factor, (PDGF) and several
others. VEGF is a 45 kDa glycoprotein and six isoforms
of human VEGF have been identified that differ in their
tissue specific expression pattern as well as in their bio-
chemical and biological properties. VEGF as an angio-
genic factor, multiple downstream signaling pathways
have been implicated in the modulation of VEGF-depen-
dent effects, including the regulation of cell survival,
gene expression, cell proliferation and cell migration
[16,17]. However, all isoforms will bind the two VEGF
receptors [18,19]. Both receptors, VEGF receptor-1
(VEGFR-1 or Flt-1) and VEGFR-2 (or Flk-1/KDR) exhi-
bit tyrosine-kinase activity (RTK).
Adaptation to hypoxia involves appropriate alterations
in the expression of a number of angiogenesis-respon-
sive genes. Hypoxia-induced genes are regulated by a
critical transcriptional factor, namely hypoxia inducible
factor-1 (HIF-1a) [11]. HIF-1a is a widely expressed
heterodimeric protein composed of HIF-1a and ARNT
subunits, both of which belong to the basic helix-loop-
helix PAS family [20]. HIF-1a is a heterodimeric tran-
scriptional factor that activates the transcription of sev-
eral genes in response to low oxygen tension, including
erythropoietin, transferrin, inducible nitric oxide
synthase and VEGF. HIF-1a binds to DNA motifs
hypoxia response elements (HREs) which have been
found in the isoforms of a variety of genes that are over-
expressed during neovascularization. Another factor,
nuclear factor kappa B (NFB) regulates the transcrip-
tion of many genes required for neovascularization, cells
adhesion, differentiation, proliferation and apoptosis
[21-23]. Hypoxia can activate NFB, which in turn, reg-
ulates the multiple human pathologies, including retinal
neovascularization, diabetic retinopathy, inflammatory
diseases, atherosclerosis and cancer. Hypoxia-mediated
NFB activation initiates a pathway that involves phos-
phorylation and subsequent degradation of the NFB
inhibitor (IKB) resulting in the cytoplasmic release and
nuclear translocation of NFB.
Many angiogenic factors are also implicated in neovas-
cularization in the eye, where the source could be retina,
pericytes, EC, or RPE. It has been suggested that an
imbalance of growth factors may have a pathogenic role
in retinal neovascularization. Additionally, hypoxia has
been shown to induce the expression of VEGF in
matured retinal cells [24-29]. To the best of our knowl-
edge, this is the first study with HRPC co-cultured with
HUVEC to examine as a model of retinal neovasculari-
zation. Our use of the HRPC cells as a model of retinal
neovascularization was based on the fact that HRPCs
represent only about 0.2% of pigmented cells in the cili-
ary margin zone, and has been shown to be multipotent,
proliferative and express the neuroectodermal marker
nestin [25]. HRPC can differentiate into retinal neurons
and Mûller glia, including photoreceptors [30]. The aim
of this study was to elucidate the mechanism of interac-
tion between HRPC and HUVEC that modulates a neo-
vascularization response. We established a trans-well co-
culture system of endothelial cells (HUVEC) and HRPC
under normoxia and hypoxia conditioned, and evaluated
the effect of these environments as well as conditioned
media from normoxia or hypoxia obtained from both
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cells on the angiogenic response. Further, we also stu-
died the role of HUVEC-CM on the translocation of the
transcriptional factors NFB and HIF-1a in the HRPC
cells. We found that hypoxia can affect both HUVEC
and HRPC cells’ gene expression independently. The
factors are released into the media and can modulate
endothelial-retinal cell interactions, which may lead to a




Human retinal progenitor cells (HRPC) and umbilical vein
endothelial cell (HUVEC) propagation
The human retinal progenitor cells (HRPC) were char-
acterized by and obtained from Dr. Kamla Dutt [30-32].
Cells were maintained routinely in Dulbecco Modified
Eagle Medium (DMEM): nutrient mixture F-12 (1:1);
DMEM/F-12 (Invitrogen) supplemented with 10% fetal
bovine serum, 2mM L-glutamine, 0.075% sodium bicar-
bonate. The cells cultured were maintained at 37°C in a
humidified air/CO2 (95:5, v/v) atmosphere and used 42-
45 passages. At confluence, the media were replaced
with serum-free 24 h before; cells were used for co-cul-
ture or exposed to normoxia or hypoxia conditions.
Human umbilical vein endothelial cells (HUVEC) were
obtained as primary cultures from Cambrex Biosciences
(San Diego, CA). HUVEC (passages 3-6) were cultured
routinely in EMG-2 Bullet kit composed of endothelial cell
basal medium-2 (EBM-2 medium) supplemented with 2%
fetal bovine serum, human VEGF, human epidermal
growth factor (hEGF), insulin-like growth factor-1, and
ascorbic acid, gentamicin sulfate hydrocortisone, and
heparin, as described by the manufacturer protocol [33].
When HUVEC were cultured in co-culture with HRPC or
exposed with hypoxia, cells were maintained in serum free
EMG-2 medium without any growth factor for 24 h.
Co-culture of HRPC and HUVEC in transwell systems
Non-contacting and contacting co-culture transwell cell
culture systems were developed to study the cross biolo-
gical activity of HRPC and HUVEC. The non-contacting
co-cultured cells (Figure 1A) were prepared as follows:
Transwell Co-culture Models
HRPC and HUVEC cultures 
Examine under Normoxia (20% O2, 5% 










Figure 1 Two different modes of transwell co-culture system. (A) Non-contact: HRPC and HUVEC cells were co-cultured in two different
compartments (insert membrane and well); cells may communicate through the pore of the membrane. (B) Contact: both cells may be cultured
on the insert membrane thus allowing extensive and direct cell-cell interactions
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HRPC cells were plated on the bottom of the six-well
transwell cell culture system (Pore size 0.4 μm; Costar
Corp. USA) using the complete media and culture
environment as describe above. The HUVEC were cul-
tured onto the membrane of transwell cell culture
inserts and allowed to grow overnight using the above
mentioned condition. The next day the cells were
washed with the serum-free media and incubated for 24
h in serum-free medium without growth factors. After
24 h of growth in serum-free media, the HUVEC cul-
tured on membrane transwell insert were placed into
the six-well pates cultured containing the HRPC to initi-
ate the experiment.
The HRPC and HUVEC cells are grown in the non-con-
tacting co-culture system for 24 h, which allow bidirec-
tional diffusion of soluble factors. Cultures were serum
and growth factor deprived for 24 h before the normoxia/
hypoxia environment studies were initiated. All cultures
were 80-85% confluent by visual inspection on the day
that hypoxia experiments were initiated. The second set of
the cell-cell interactions were examined between HRPC
and HUVEC using contacting co-culture model main-
tained in transwell plates (Figure 1B). Briefly, the HRPC
were seeded on the bottom on transwell system mem-
brane inserts and HUVEC were seeded on the top. All cul-
tures were incubated at 37°C in a humidified air/CO2
(95:5, v/v) atmosphere for the duration of the experiment.
The next day media were aspirated and replaced with
fresh EMB medium without serum and growth factors for
24 h before the normoxia/hypoxia conditions. Finally, the
transwell plates were placed under normoxia and hypoxia
incubators for specified period of time.
Hypoxia Treatments
Monolayer cultures were incubated in a hypoxic environ-
ment by the following protocol. Briefly, media were pre-
equilibrated with a hypoxic gas mixture (1%O2, 5%CO2,
and 94%N2). Cultures were replenished with the hypoxic
medium, placed in the hypoxia incubator and maintained
for 24 h to 48 h at 37°C. Control monolayer cultures
were maintained in a normoxic environment, which
refers to standard cell culture in a humidified incubator
(20% O2, 5% CO2, and 75% N2). All cells maintained in
normoxic condition showed no morphological changes
by light microscopy. The trypan blue exclusion test of
cell viability showed cells to be >98% viable, and could
then be sub-cultured normally. Cells incubated under
normoxia conditions from the same batch, and subse-
quently sub-cultured, were used as control.
Preparation of HRPC/HUVEC conditioned medium (HRPC-
CM/HUVEC-CM)
In a separate set of experiments, we evaluated the bio-
logical activity of conditioned medium (CM) obtained
from HRPC (as HRPC-CM) and HUVEC (as HUVEC-
CM) in normoxia and hypoxia condition [Figure 2].
HRPC cells were seeded in a 75 cm2 flasks with
DMEM/F-12 with above mentioned supplements.
HUVEC cells were cultured in EBM-2 medium with
above mentioned supplements for 24 h. The cells were
grown to 80% confluence then washed twice with the
respective serum-free medium. Finally, the medium
was replaced again with serum-free medium for
another 24 h in normoxia and hypoxia condition. The
CM from both cells under normoxia and hypoxia were
collected, centrifuged at 1000 rpm for 10 min to
remove cellular components and filtered through 0.2-
μm filters (Millipore, Billerica, MA) before use. Med-
ium from dishes under normoxic conditions was used
as a control. The aliquots were stored at -80°C in a
freezer.
Quantifying secreted VEGF protein levels by ELISA
Changes in environmental factors in the cells culture
can be differentially regulated by diverse signals. There-
fore, we thought it was important to determine how
hypoxia and co-culture interact in the regulation of
VEGF secretion. Conditioned medium were collected, as
described above, for the determination of secreted
VEGF levels by ELISA. VEGF was assessed using com-
mercially available human VEGF-ELISA kit (R&D Sys-
tems, Minneapolis, MN), performed according to
manufacturer’s instructions and normalized to protein
content (BioRad, CA). The experiments were repeated
three times in triplicates and are shown as mean ±
SEM. The level of VEGF is expressed as pictograms of
VEGF protein per milligram protein.
Capillary-like Tube Formation Assays
The effects secreted factors from HRPC-CM under nor-
moxia and hypoxia were examined in the formation of
capillary tube-like structures by HUVEC. The matrigel
assay is a frequently used method for detection of angio-
genesis in vitro. Briefly, the growth factor reduced
Matrigel (BD Biosciences, San Jose, CA) was added to
pre-chilled 48 well culture plates and allowed to poly-
merize at 37° C for 2 h. HUVECs (4 × 105 cells/well)
were plated in the Matrigel-coated plates and the cells
cultured in HRPC-CM from normoxia and hypoxia con-
ditioned for 24 h at 37°C with 5% CO2. To study the
role of VEGF in capillary tube formation, parallel cul-
tures were treated with 20 ng/ml neutralizing anti-
VEGF antibody, which were added at the time of
HUVEC seeding. VEGF (50 ng/ml) was used as the posi-
tive control. Angiogenesis (capillary cord formation)
were evaluated after culturing for 24 and 48 h and
resulting tube-like capillary structures were examined by
using an Olympus TMS inverted phase contrast
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microscope. Photomicrographs were documented with
an Olympus digital camera.
Evaluating the expression of angiogenic protein by
Western blot
The total cellular protein was isolated and used to
examine the expression of angiogenic factors such as:
VEGF, VEGF receptors (VEGFR-1 and VEGFR-2), and
transcriptional factors (HIF-1a and NFB). All these
proteins play a major role in regulation of the retinal
neovascularization. Briefly, after normoxia/hypoxia incu-
bation for 24 h, media were collected and cells were
washed with the PBS. The total proteins were extracted
from the cell layers using M-PER Mammalian Protein
Extraction Reagent (Pierce; CA) containing a protease
inhibitor mixture (Sigma, CA). The protein extracts
were centrifuged for 15 min at 15,000 rpm at 4° C and
the supernatant were saved for further analysis. Total
protein concentration of each sample was determined
by the Bradford method as per manufacturer protocol
(BioRad, CA) with bovine serum albumin as a standard.
30 μg total cellular proteins were analyzed on SDS/
PAGE under reduced conditions. Before loading, all cell
lysates were added to an equal volume of Laemmli sam-
ple buffer and heated at 95°C for 5 min, and samples
were resolved by SDS-PAGE. The fractionated proteins
were transferred to a polyvinylidene difluoride (PVDF)
membrane. The membrane was blocked with 5% nonfat
milk (BioRad, CA) in Tris buffered saline (TBS) with
0.05% Tween-20 (TBS-T) for 1 h at RT followed by
incubation for 2 h with the primary antibodies in 2%
milk in TBS-T. The membrane was washed three times
with TBS-T for 10 min, and then incubated with the
HRP-conjugated secondary antibodies, diluted in 2%
milk in TBS-T, for 1 h, followed by three washes of 15
min in TBS-T. All membranes were probed with antibo-
dies to b-actin to correct for loading and transfer differ-
ences among samples. The membranes were visualized
by an enhanced chemiluminescence (ECL) Western
Blotting Analysis System (Amersham).
Evaluating the expression of angiogenic transcriptions by
RT-PCR
Total RNA was extracted from cultures (control mono-
layer and co-cultured under normoxia and hypoxia con-
ditions) using the extraction solution Triazol reagent
(Invitrogen, CA) according to the supplier’s instructions.
The purity and concentration of RNA were quantitated
by absorbance measurement at 260/280 nm. The quality
of RNA was also checked by the agarose gel electro-
phoresis. Total RNA (1 μg from each sample) was run
on 1% agarose gel, then stained with ethidium bromide,
and examined the 28S and 18S rRNA bands on a UV






Figure 2 Conditioned Medium collection. Experimental protocol used in this study to collect the conditioned medium from normoxia/hypoxia
environments. Collected conditioned medium were used to examine the effect of the factors released by HRPC on HUVEC and effect of the
factors released by HUVEC on HRPC.
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observed in any total RNA samples. The extracted RNA
was then analyzed by RT-PCR for VEGF, VEGF recep-
tor-2 (VEGFR-2), and transcriptional factors (NFkB and
HIF-1a). The transcription of the housekeeping gene
18S RNA was used as internal controls (Ambion Inc.
TX). The list of primers for RT-PCR to provided in
Table 1. The reverse transcriptase (RT) reaction was
performed with 1 μg of RNA, random hexamers, and
Superscript II reverse transcriptase (Invitrogen, CA),
according to the manufacturer’s instructions. RT-PCR
was conducted using the Gene Amp PCR System 2400
(Applied Biosystems) under the conditions described in
the figure legends. The reaction mixture was first dena-
tured at 95°C for 10 min, and the PCR conditions
applied for 30 cycles. The amplified products were ana-
lyzed by electrophoresis on 1.8% agarose gels, and the
ethidium bromide stained bands were visualized by UV
transillumination. All images were saved in TIFF format.
The levels of expression were quantitated by densit-
ometer scanning. The target PCR products were ana-
lyzed by determining the intensity of band by gel-pro
software (USA) which is a PC version of the image ana-
lysis software.
Expression and Translocation of NFB and HIF-1a
We also examined the expression and translocation of
NFB and HIF-1a in HRPC cultured in HUVEC-CM
(normoxia/hypoxia) by western blot analysis and immu-
nofluorescence studies.
Immunofluorescence studies
HRPC cells were cultured on 4-well chamber slides to
approximately 80% confluence; then the cells were
grown overnight under serum free medium. The next
day, the medium was removed and cells were further
cultured with HUVEC-CM (normoxia and hypoxia) at
37o C in a humidified air/CO2 (95:5, v/v) atmosphere
for 24 h. Cultures were then rinsed with pre-warmed
PBS and fixed with 4% paraformaldehyde (Sigma) in
PBS for 10 min at room temperature. The fixed cultures
were washed and permeabilized with a solution of PBS
containing 0.1% Triton X-100 (sigma) in PBS. Non-spe-
cific antibody binding sites on the cells were blocked by
using 10% goat serum for 1 h at room temperature
before incubation with primary antibodies. Cultures
were then incubated with primary antibody rabbit poly-
clonal antibody against NFB and HIF-1a (Santa Cruz
Biotechnology, CA) overnight at 4° C. Cells were washed
and incubated with FITC-conjugated anti-rabbit IgG
(1:100 dilution) for 1 h at room temperature. For
nuclear counter-stain DAPI (Molecular probe; CA) was
used as per manufacturer’s protocol.
Protein translocation
Cultures were incubated as described above for culture
of normoxia/hypoxia HUVEC-CM-treated cells. After
incubations, the medium was removed and cultures
were washed with PBS. Cytoplasmic and nuclear pro-
teins for Western blots were prepared using Nuclear
Extract kits (Active Motif, Carlsbad, CA) according to
manufacturer’s suggested protocols. Protein concentra-
tion was determined by the Bradford method (Bio-Rad,
Richmond, CA). Translocation of NFB and HIF-1a
were determined by western blotting as described above.
Results
HRPC-CM induces neovascular responses by HUVEC
The effect of HRPC-CM from hypoxia or normoxia
treated cells on the induction of capillary-like structures
(angiogenesis or neovascularization) in vitro was investi-
gated using a well-established model - the matrigel in
vitro angiogenesis assay. Control HUVEC (Figure 3A)
cultures were grown on matrigel-coated plates for 24 h
in serum free conditions. Treatment of HUVEC with
normoxic HRPC-CM showed very weak neovascular
response (Figure 3B) although somewhat blunted com-
pared to that induced by hypoxic HRPC-CM (Figure
3D). This effect was also attenuated by the simultaneous
treatment with anti-VEGF antibodies (Figure 3C). On
the other hand, HUVEC treated with hypoxic HRPC-
CM for 24 h was found to have the highest neovascular
response (Figure 3D) which was attenuated by the
simultaneous treatment with anti-VEGF antibodies (Fig-
ure 3E). This suggests that the primary factor in the
HRPC-CM responsible for the neovascular response
may be VEGF.
VEGF secretion by individual cultures and co-cultures
We measured the levels of VEGF released into the cul-
ture media of individual cultures of HRPC and
HUVEC as well as co-cultures of these cell lines, fol-
lowing cultures under hypoxic conditions for 6, 12, 24
and 48 h. Control cultures were treated the same
except they were maintained in normoxic conditions.
Co-cultures were setup as shown in Figure 1. Media
from the various cultures were collected and analyzed
for the levels of total VEGF by ELISA. We found that
hypoxia clearly enhanced VEGF secretion by all the
cultures (Figure 4). For all cultures, the VEGF level in





NFB 5’- GCC ATG GAC GAA CTG TTC CCC-3’
5’- GCC ATG GAC GAA CTG TTC CCC-3’
HIF-1a 5’-GTCGGACAGCCTCACCAAACAGAGC-3’
5’-GTTAACTTGATCCAAAGCTCTGAG-3’
18S RNA QuantumRNA Classic II (Ambion Inc. TX)
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the media shows a time-dependent increase from 6 to
48 hours. At the 24 h time point, there was a five-fold
increase in VEGF level for HRPC (Figure 4A) and
HUVEC (Figure 4B). Our co-culture data showed an 8-
to 10-fold increase for the non-contacting or contact-
ing co-cultures (Figure 4C & D) for hypoxia treated
cultures compared to normoxia controls. There was no
significant difference noted for VEGF secretion by cells
in co-culture with contacting or non-contacting
between the two cell lines.
Effect of hypoxia on VEGF and VEGFR-2 expression
We also examined the transcriptional expression of
VEGF and VEGFR-2 as well as the expressions VEGF
and VEGFR-2 protein by cultures maintained in hypoxia
for 24 hr. Figure 5A and 5B show that hypoxia
treatment of either HRPC or HUVEC cultured alone
resulted in a 2- to 2.5-fold higher expression of VEGF
and VEGFR-2 mRNA. However, hypoxia was able to
induce about a six-fold higher expression of VEGF and
a four-fold higher expression of VEGFR-2 by co-cultures
of HUVEC and HRPC. There were no significant differ-
ences noted for VEGF and VEGFR-2 expression when
the two cell lines were co-cultured with contacting or
non-contacting set-ups. These findings for co-cultures
appear to be an additive effect of the responses of the
individual cell lines.
We also observed that hypoxia induced an increase
in VEGF and VEGFR-2 protein expression following
western blot analysis [Figure 5E and 5F]. Our Western
blot data support mRNA data with the low protein




Figure 3 Effect of normoxia and hypoxia HRPC-CM on capillary tube formation in the HUVEC. Formation of capillary tubes by HUVECs in
matrigel was evaluated in a condition medium obtained from normoxia and hypoxia HRPC-CM (see Material and Methods section).
Representative photographs of Matrigel-coated cultured HUVEC cells after incubation with A) in serum-free medium, B) in HRPC-CM (normoxia),
C) in HRPC-CM (normoxia) with anti human VEGF antibody; D) in HRPC-CM (hypoxia), E) in HRPC-CM (hypoxia) with anti human VEGF antibody.
When HUVEC exposed to the basal medium or normoxia HRPC-CM, they were minimally spread out (A, B). In contrast, HUVEC were exposed to
the hypoxia HRPC-CM within 24 hr assembles into capillary tube structures (D). When VEGF neutralizing antibodies were added to the
conditioned medium, the tube formation was attenuated (C, E). Representative photomicrographs (20X magnification) are shown. Data shown
are representative of three experiments done in triplicate.
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HUVEC were cultured under normoxia environment.
We have found that exogenous VEGF expression is
increased in HRPC and HUVEC cultured alone under
hypoxia condition as compared with normoxia. There
was a four-fold increase in VEGF expression by HRPC
exposed to hypoxia for 24 h, as compared with nor-
moxia. When HRPC were cultured in presence of
HUVEC under hypoxia, there was a further two-fold
increase in VEGF expression, compared to HRPC cul-
tured alone under hypoxic conditions. In addition, our
data indicated that hypoxia was capable of inducing
not only VEGF expression, but also its receptor -
VEGFR-2 when HRPC were co-cultured with HUVEC
for 24 h. Data from RT-PCR and Western blot analysis
are consistent with our VEGF ELISA results, and
showed an increased in VEGF in all the hypoxia treat-
ments and co-cultures compared with normoxia
controls. These results suggest the association of
VEGF-VEGFR-2 signaling regulate the retinal
neovascularization.
Role of hypoxia on the expression of NFB and HIF-1a
Cultures of HRPC and HUVEC (alone or as co-cul-
tures), maintained under normoxia (control) and
hypoxia, were harvested, then total RNA and protein
extracted. These extracts were used to measure the
expression of transcription factors NFB and HIF-1a.
Figures 6A shows that either cell line alone constitu-
tively expressed low levels of NFB mRNA under nor-
moxia conditioned. Hypoxia treatment of either HRPC
or HUVEC resulted in a three- and two-fold increase in
NFB mRNA expression compared with normoxia con-
trols, respectively. Additionally, we found that under
control (normoxia) conditions, HRPC co-cultured with
HUVEC as either contacting or non-contacting cultures,
showed significantly higher levels of NFB compared to
single-cell cultures maintained similarly. In contrast,
hypoxia treatment resulted in a much higher level of
expression for NFB (5-fold), compared to control co-
cultures. There was more than a seven-fold induction of































































Figure 4 The effects of hypoxia and co-cultured of HRPC and HUVEC on VEGF secretion. Both HRPC and HUVEC were cultured singly and
as co-cultures under normoxia (■) and hypoxia (□) conditions for specified time and medium were collected as described in Material and
Methods. The secreted VEGF was determined by ELISA as described in above. The values presented as bar graphs give the means ± S.E.M. of
quadruplicate from three independent experiments. The effects of both cells cultured/co-cultured on the secretion of endogenous VEGF protein
are statistically significant under hypoxia conditions. Data shown is mean ± S.E.M. of three independent experiments (n = 4), *P>0.001.
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control co-cultures. To confirm our RT-PCR results, we
also measured the protein expression for these tran-
scriptional factors using western blotting. Total cellular
proteins were isolated from culture cells maintained
under hypoxia and normoxia (controls) for 24 h. Figure
6C shows western blots for NFB; we found a 2.6-fold
increase in NFB expression by HRPC exposed to
hypoxia for 24 h, compared with normoxia controls. A
similar observation was found for hypoxia-treated





Figure 5 Confirmation of gene expression. Representative RT-PCR showing the expression of mRNAs for VEGF (A) and VEGFR-2 (B) in HRPC,
HUVEC cultured alone and HRPC co-cultured with HUVEC under normoxia and hypoxia conditioned for 24 h. Densitometric analysis of mRNA
expression of VEGF (C) and VEGFR-2 (D) presented as a ratio of VEGF and VEGFR-2 mRNA over 18S RNA. Representative Western blot analysis
using VEGF (E) and VEGFR-2 (F) antibodies confirm the expression levels of these proteins. VEGF (homodimer, molecular mass ~ 44kDa) and
VEGFR-2 (homodimer, molecular mass ~ 220 kDa) were expressed on HRPC and HUVEC cells. A b-actin antibody was used to normalize
densitometer tracing values for differences in loading and the transfer efficiencies. Both of the experiments were repeated three times with
similar results. Figure (G, H) bar graphs of quantitative analysis of Western blot data presenting calculated means +/- S.E. of densitometer tracings
values from three independent experiments.
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expression. Lastly, we found that hypoxia was capable of
significantly increasing the levels of NFB expression by
four-fold for co-cultures, whether non-contacting or
contacting.
Figure 7 showed the effects of hypoxia treatment on
HIF-1a expression for single and co-cultured cells. Simi-
lar to the results found for NFB, HIF-1a mRNA
expression showed a two-fold increase in following
hypoxia treatment for both HRPC and HUVEC cultured
alone (Figure 7A). We also found that co-culture of
these two cell lines resulted in a two-fold higher level of
HIF-1a mRNA compared to single-cell HRPC cultures
maintained similarly. Hypoxia treatment induced a four-
fold increase in HIF-1a expression by co-cultures, com-
pared to normoxia control co-cultures. Figure 7C shows
that hypoxia resulted in a three-fold increase in HIF-1a
protein by either HRPC or HUVEC cultured alone, but
increased HIF-1a expression by six-fold for co-cultures.
Contacting or non-contacting co-cultures had similar
responses.
Effect of HUVEC-CM on the Subcellular Localization of
NFB and HIF-1a
When HRPC single-cells cultures were treated for 24 h
with either HUVEC-CM collected under normoxia (con-
trol) or hypoxia conditions, we observed significant
effects on possible nuclear translocation of NFB and
HIF-1a. Figure 8A and 8B show immunofluorescent
photomicrographs of HRPC treated with normoxic or
hypoxic HUVEC-CM, respectively. With normoxic
HUVEC-CM, there was higher NFB immunofluores-
cence observed in the cytoplasm. This finding was sub-
sequently confirmed by measuring the expression of
NFB protein in cytosolic and nuclear extracts using
western blotting analyses (Figure 8C). Treatment with
hypoxic HUVEC-CM resulted in the activation of NFB
and promoted its translocation to the nuclear compart-
ment (Figure 8B) and resulted in higher expression of
NFB in the nuclear fraction of HRPC and correspond-
ing decrease in cytoplasmic NFB (Figure 8D).
A similar finding was seen for the subcellular localiza-
tion of HIF-1a (Figure 9). HRPC treated with the con-
trol normoxic HUVEC-CM showed HIF-1a was
localized primarily in the cytoplasm (Figure 9A). Subse-
quently, treatment with hypoxic HUVEC-CM resulted
in the translocation of HIF-1a to the nucleus (Figure
9B). Western blotting of proteins extracts from the cyto-
plasmic and nuclear fraction also showed a similar
change. Treatment with hypoxic HUVEC-CM resulted
in a higher expression of HIF-1a in the nuclear fraction
compared to control cultures treated with normoxic
HUVEC-CM (Figure 9C and 9D). Thus, these studies
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Figure 6 RT-PCR and Western blot analysis of NFB. Total RNA and total protein were extracted from HRPC and HUVEC cultured alone or
co-cultured under normoxia and hypoxia conditioned for 24 h. The expression of NFB was measured by (A) electrophoresis of RT-PCR, (C)
Western blot analysis in the HRPC and HUVEC. Figures (B, D) the band intensities corresponding to the NFB were quantified by image analysis
using a Bio-Rad scanning densitometer and Quantity One analysis software. Data were shown as ratio of NFB densities to that of 18S RNA for
RT-PCR and b-actin antibody was used to normalize Western blot for differences in loading and the transfer efficiencies. All data were expressed
as mean +/- SE and results are representatives of three independent experiments.
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suggest that the hypoxia HUVEC-CM promoted the
translocation of both NFB and HIF-1a to the nuclear
compartment of HRPC.
Discussion
Retinal neovascularization is a complex process that is
not completely understood. In retinal neovascularization,
there are abnormally formed blood vessels and fibrous
tissue that grow from the retina or the optic disk along
the posterior surface of the vitreous. These retinal capil-
laries do not normally invade the vitreous or extend
beyond the inner plexiform layer of the retina. However,
in retinal diseases, e.g., diabetic retinopathy, the disrup-
tion of the balance between angiogenic and anti-angio-
genic factors favors neovascularization, which enters the
sub-retinal space, where leakage and bleeding lead to
retinal detachment and photoreceptor death [25].
Clearly, the process of retinal neovascularization is
mediated by the regulation of several angiogenic indu-
cers, inhibitors, their respective receptors, and transcrip-
tional factors. VEGF is a potent angiogenic and
permeability enhancing factor causally linked to neovas-
cularization in cancer, wound healing, diabetic retinopa-
thy, and age-related macular degeneration [14,34].
Several reports have shown that VEGF is produced by
several cell types within the eye (retinal pigment
epithelial cells, glial cells, retinal capillary pericytes,
endothelial cells, Müller cells and ganglion cells) [ 35 ]
and play a role in the development of retinal neovascu-
larization [13,36,7]. Aiello et al. [37] showed that VEGF
played a significant role in mediating retinal neovascu-
larization in diabetic patients. Using animal models of
ischemic retinopathy and iris neovascularization, several
researchers found that VEGF expression is upregulated
in the retina during neovascularization [13,7,8,38].
Furthermore, inhibiting VEGF using VEGF receptor chi-
meric proteins, neutralizing antibodies, and antisense
oligonucleotides in these animal models could reduce
both retinal and iris neovascularization. Finding
increased VEGF levels during retinal neovascularization
has resulted in a controversy as to whether VEGF itself
is sufficient to stimulate retinal neovascularization.
Increase VEGF expression could be the result of the
retina microenvironment (hypoxia or ischemia) as well
as changes in other factors such as pigment epithelium-
derived factor (PEDF). The balance between the expres-
sion of VEGF and pigment epithelium-derived factor
(PEDF) in modulating retinal neovascularization was
investigated by Zhang and co-workers [39]. These
researchers found a reciprocal interaction between
VEGF and PEDF in retina; significant increases in VEGF
expression was observed following silencing of the PEDF
ņ+ ņ+ ++ ņ ņ






























HUVEC NC C NC
ņ+ ņ+ ++ ņ ņ




























HUVEC NC C NCA C
B D
Figure 7 RT-PCR and Western blot analysis of HIF-1a. Total RNA and total protein were extracted from HRPC and HUVEC cultured alone or
co-cultured under normoxia and hypoxia conditioned for 24 h. The expression of HIF-1a was measured by (A) electrophoresis of RT-PCR, (C)
Western blot analysis in the HRPC and HUVEC. Figures (B, D) the band intensities corresponding to the HIF-1a were quantified by image analysis
using a Bio-Rad scanning densitometer and Quantity One analysis software. Data were shown as ratio of HIF-1a densities to that of 18S RNA for
RT-PCR and b-actin antibody was used to normalize Western blot for differences in loading and the transfer efficiencies. All data were expressed
as mean +/- SE of three independent experiments.
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gene. Hypoxia has been shown to upregulate VEGF
mRNA in retinal endothelial cells, pericytes, RPE cells,
Muller cells and ganglion cells [14,40]. Our studies
show that both HUVEC and HRPC express basal levels
of VEGF and VEGFR-2 mRNA and protein, which was
significantly increased by hypoxia treatment. Addition-
ally, we found that co-cultures of these cell lines
resulted in a synergistic increase in the expression of
both VEGF and VEGFR-2, similar to that induced in
single cultures by hypoxia. In fact, co-cultures treated
with hypoxia showed a pronounced increase in the
expression of both VEGF and VEGFR-2. However, con-
tacting co-culture did not show a difference in response
to hypoxia treatment from that of non-contacting co-
cultures. Recently, Dardix and coworkers [41] also
investigated the effects of co-culture (with retina pig-
mented epithelial cells - RPE) and hypoxia on endothe-
lial cell expression of VEGF. These researchers reported
that contact co-cultures upregulated both VEGF mRNA
and protein expression to the same degree as hypoxia
alone. In contrast to our findings, these researchers
found that non-contacting co-cultures did not show an
effect. However, these researchers used RPE cells for co-
cultures as well as utilized CoCl2, a hypoxia mimetic to
study the effect of hypoxia. In our studies we used
human retinal progenitor cells (HRPC) cells for co-cul-
tures; these cells express and secrete VEGF, among
other soluble factors those have direct effects on
endothelial cells [33]. In addition, we also used hypoxic



















































Figure 8 Nuclear translocation of NFB in HRPC. The HRPC cells were cultured with normoxia/hypoxia HUVEC-CM for 24 hr and subcellular
localization were done with immunofluorence and Western blot study. (A) HRPC cells were cultured with normoxia HUVEC-CM and intracellular
location of NFB was determined by immunofluorescence using primary anti-NFB antibody and secondary antibody FITC labeled IgG. Nuclei
were counterstained with DAPI. The immunofluorescence images observed in higher magnification showed that NFB was more localized to the
cytoplasm and less to the nuclei of the HRPC cells. (B) HRPC cells were cultured with hypoxia HUVEC-CM and labeled with anti-NFB and
nucleus staining with DAPI (blue). Hypoxia HUVEC-CM activates NFB and translocated the most of the NFB protein in the nuclear region of
the HRPC cells. (C) Protein were extracted from the nucleus and the cytoplamic fraction of the HRPC cells after the cells were exposed with
normoxia/hypoxia HUVEC-CM for 24 hr. 20 μg of protein from nuclear extracts and cytosol were separated by SDS-PAGE followed by western
blotting with primary anti-NFB antibody and followed by the secondary antibody HRP-conjugated. (D) Densitometry quantification of signal
intensities of NFB and b-actin was performed using a Bio-Rad scanning densitometer and Quantity One analysis software. Results are in
arbitrary units and expressed as mean +/- SE of three independent experiments.
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which may activate additional mechanisms not seen
with the hypoxia mimetic.
Hence, our studies are consistent with the idea that
hypoxia-inducing VEGF expression will lead to an
enhanced neovascular response. These data not only
highlight the important angiogenic properties of VEGF,
but they also demonstrate the autocrine ability of VEGF
to regulate the synthesis of multiple angiogenic proteins
[42]. The autocrine effect of VEGF on retinal elements
previously has been reported, for both retinal glial cells
[43,44] and RPE cells [26], but not for the HRPC. To
our knowledge, however, the regulation of VEGF recep-
tor expression has not yet been investigated in retinal
neovascularization induced by hypoxia co-culture sys-
tem. Several lines of evidence indicate that enhanced
VEGF expression in response to hypoxia is due to tran-
scriptional activation [45,46]. Furthermore, this is the
first time HRPC cells have been shown to have VEGF
receptors (VEGFR-2) and induced the expression after
hypoxia treatment. If similar autocrine functions of
VEGF were present in HRPC cells, this would explain
our observation of increased expression of VEGF and
VEGFR-2 receptor after hypoxia and co-cultured
conditioned.
It is well-established that hypoxia will stimulate neo-
vascularization through inducing HIF1a, which translo-
cates into the nucleus, binds to the hypoxia-response
element, and up-regulates the expression of VEGF and
other angiogenic factors [24]. Several studies have
shown that hypoxia induces VEGF expression in
matured retinal cells, which may play a major role in
development of many retinal diseases. Our data from
nuclear staining pattern and the immunoblotting of
nuclear extracts indicate that HIF-1a, present in the
cytoplasm of HRPC treated with normoxia HUVEC-
CM, did translocate to the nucleus when cells were trea-
ted with hypoxia HUVEC-CM. HIF-1 may also have a





















































Figure 9 The effect of hypoxia HRPC-CM on level and distribution of HIF-1a. (A) HRPC cells were cultured with normoxia HUVEC-CM (B)
HRPC cells were cultured with hypoxia HUVEC-CM. Cells were analyzed by immunofluorescence with primary antibody that recognize the HIF-
1a and followed by secondary antibody FITC- conjugated IgG. Cells were counterstained with DAPI (blue) to label nuclei and analyzed using
fluorescence microscopy. (C) Western blots analysis of HIF-1a in cytoplasmic and nuclear fractions were obtained from the HRPC cells were
cultured with normoxia/hypoxia HUVEC-CM. (D) Densitometry quantification of signal intensities of HIF-1a and b-actin. Results are representatives
of three independent experiments.
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the constitutive level of HIF-1 expression in adult nor-
moxic retina is much higher than that found for heart
and lung, where it was undetectable by immunoblot or
immunohistochemistry. VEGF is also constitutively
expressed in the retina and it is possible that this is dri-
ven by the constitutive expression of HIF-1.
Another mechanism that may be activated by hypoxia
treatment is NF-B, which has also been suggested to
play an important role in the induction of retinal neo-
vascularization [21,23]. In the present study, we found
that hypoxia has increases expression of NFB mRNA
and protein in HRPC/HUVEC cultured and co-cultured
conditions. The hypoxic sensitivity of the NF-B path-
way and a wide variety of in vitro studies have demon-
strated that exposure of various cell types to hypoxia
activates NF B signaling pathways. There are several
reports that NFB was activated in retinal glial cells,
vascular endothelial cells, pericytes, and macrophage/
microglia, all of which participate in neovascular disor-
ders such as diabetic retinopathy. In the retina, NF-B
is localized in sub-retinal membranes and in microves-
sels and is activated very early in the course of develop-
ment of retinopathy in diabetes. The activation of NFKB
in retinal pericytes is responsible for the hyperglycemia-
induced accelerated loss of pericytes observed in dia-
betic retinopathy. An inhibitor of NF-B, PDTC inhib-
ited NF-KB activation and reduced retinal
neovascularization without discernible toxicity in a
mouse model [45,46]. It also revealed that NF-KB might
provide a basis for a specific and effective therapeutic
regimen for various diseases associated with undesired
angiogenesis. Normally, NFB is present in the cyto-
plasm as a complex with members of the IkB inhibitor
family. The hypoxia-induced activation of NFB could
result in the degradation of IkB. This in turn exposes
the nuclear localization signal, allowing NFB to be
transported into the nucleus. In this study, we investi-
gated the effects of normoxia/hypoxia exposed HUVEC-
CM on NFB nuclear translocation. Our studies showed
that the HRPC cells did not significantly affect the
nuclear translocation of NFB when the cells were
exposed with normoxia HUVEC-CM. However, nuclear
translocation of NFB was induced by hypoxia HUVEC-
CM. Since nuclear localization of NF-B is thought to
be equivalent to NF-B activation, we have shown that
NF-B was activated in HRPC cells by hypoxia HUVEC-
CM, which may have triggered the transcription of NF-
B dependent genes and regulated the expression retinal
neovascularization related genes.
Conclusions
Our findings suggest that direct or indirect communica-
tions between HRPC and HUVEC cells results in the
expression and activation of transcription factors
associated with enhanced expression of pro-angiogenic
factors under hypoxic conditions. These mechanisms
play necessary roles in producing an enhanced neovas-
cular response. Furthermore, our data indicate that the
hypoxia treatment results in the up-regulation of both
mRNA and protein expression for VEGF, and VEGFR-2
through the translocation of NFB and HIF-1a to the
nucleus, resulting in enhance HRPC-induced neovascu-
larization. Hence, these results have provided a better
understanding of the underlying mechanism involved in
hypoxia-induced retinal neovascularization, which may
generate new perspectives for future retinal neovascular-
ization therapy.
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